Study population We implemented two active comparator, new user cohorts.26 The first cohort was composed of patients who started and continued on either a GLP-1 receptor agonist (dulaglutide, exenatide, liraglutide (except the 3 mg/0.5 mL formulation indicated for weight loss), lixisenatide, semaglutide) or a DPP-4 inhibitor (alogliptin, linagliptin, saxagliptin, sitagliptin, vildagliptin) for the first time between 1 January 2007 (the year these medications entered the UK market) and 31 December 2020
Failing to follow up on lab test results If a doctor fails to order the appropriate tests, misses key symptoms, or fails to act on test results, this opens the door for a medical malpractice claim
It is also important to remember that clinical trials involve carefully selected participants and close monitoring
While their side effect profile is often manageable, they can lead to serious complications
DD: Project administration, Supervision, Writing review & editing
But theres no one-size-fits-all maintenance dose